Who uses 10x Genomics Xenium?
Xenium is an in situ imaging platform that maps hundreds to thousands of RNA targets, cell by cell, in an intact tissue section. It's made by 10x Genomics. 361 bioRxiv and medRxiv preprints since April 2025 say they used Xenium, 146 in the last 6 months. Updated daily (as of Nov 16)
Is Xenium use still growing?
Yes: 146 preprints used Xenium in Jun–Nov 2026, +101% vs the previous year as a share of all preprints. This is faster than spatial biology platforms overall (+35%).
The last bar is the quarter so far. The % over each year compares it with the year before, as a share of all preprints.
How does Xenium compare with other spatial biology platforms?
Xenium is second, with 31% of their uses in Jun–Nov 2026, up from 21% the year before. Visium leads with 37%.
Which institutions use Xenium most?
The institutions using Xenium most are University of Michigan, Wellcome Sanger Institute and University of Pennsylvania.
Institutions
University of Michigan12
Wellcome Sanger Institute10
University of Pennsylvania9
University of California, San Francisco9
The University of Texas MD Anderson Cancer Center8
Where the labs are
The lab's institution and country are the corresponding author's.
Rival platforms, head to head
Latest preprints using Xenium
Who started using Xenium recently?
67 institutions posted their first preprint using Xenium since April 2025 in the last 6 months, including Seoul National University, University College London and University of Alabama at Birmingham.
Seoul National UniversityJun 4, 2026
University College LondonJun 18, 2026
University of Alabama at BirminghamJul 30, 2026
University of CaliforniaAug 4, 2026
Texas A&M UniversityAug 23, 2026
Princeton UniversitySep 16, 2026
ETH ZurichOct 6, 2026
Ottawa Hospital Research InstituteJun 1, 2026
Pennsylvania State UniversityJun 2, 2026
INSERMJun 4, 2026
An institution counts as new when its first preprint using Xenium since April 2025 was posted in the last 6 months; the date is that first preprint.
What do labs use alongside Xenium?
Preprints using Xenium most often also use Chromium, NovaSeq X and Visium. The count is preprints using both.
What is Xenium used for?
Preprints using Xenium are most often in cancer biology, neuroscience and immunology.
Fields
Cancer biology 69Neuroscience 60Immunology 55Bioinformatics 34Genomics 28Developmental biology 22
Where the work was published
- Science Immunology2
- Nature Communications2
- iScience2
- Annals of the Rheumatic Diseases2
- Arteriosclerosis, Thrombosis, and Vascular Biology1
- Epilepsia Open1
How we count which preprints use each platform
An AI model reads each preprint in full — its text, its tables and its supplementary files — and lists the products the authors used. A preprint counts for a platform when that record says the lab used it in this work, not when it only analyzed data others made with it or only mentioned it. Each preprint counts once, by its first version, if it was first posted on bioRxiv or medRxiv in April 2025 or later. We read new preprints within days of posting, so the newest ones (through Nov 16, 2026) are already counted, but those days are not complete yet. Six-month counts and growth figures stop at Nov 12, 2026, the last day nearly every preprint has been read, and charts draw a quarter that is still being counted in a paler color. A preprint that used two platforms counts for both. Each title links to the preprint on bioRxiv or medRxiv; we show no preprint text and no author names. Updated daily, most recently on Nov 16, 2026.